Tenof EM

Product Name Tenof EM
Dose/Strength 300 mg/200 mg
Packaging Size 30 Tablets
Brand

Salt

Send Enquiry



Gandhi Medicos - Low Price Medicine

Lowest price guaranteed

Gandhi Medicos - World wide Shipping

Worldwide shipping

Gandhi Medicos - Original Products

Genuine / original products

Gandhi Medicos - Fast Delivery

Fast Delivery

Category:
Description

Tenof EM (Tenofovir disoproxil fumarate + Emtricitabine) is a two-drug agent indicated to manage HIV-1 and HIV-1 pre-exposure prophylaxis (PrEP). Both tenofovir disoproxil fumarate (300 mg) and emtricitabine (200 mg) are employed in combination along with other antiretroviral agents.

Before starting Tenof EM (Tenofovir disoproxil fumarate + Emtricitabine) regimen, it is important to make sure that the patients are tested for chronic kidney disease, HIV-1 PrEP or Hepatitis B viral co-infection. Plus, these patients must have a bodyweight of greater than or equal to 35 kgs

Recommended dosage regimen of Tenof EM (Tenofovir disoproxil fumarate + Emtricitabine)

Patient population Dosage regimen (Once daily) Bodyweight Mode of administration
Adults 1 tablet of Tenof EM (Tenofovir disoproxil fumarate + Emtricitabine) ≥35 kgs Orally with or without food
Children
HIV-1 PrEP adults 1 tablet of Tenof EM (Tenofovir disoproxil fumarate + Emtricitabine) and other contraceptive methods
Kidney failure patients (Creatinine clearance: 30-49 mL/min) 1 tablet of Tenof EM (Tenofovir disoproxil fumarate + Emtricitabine) in every 48 hours

Other activities of (Tenofovir disoproxil fumarate + Emtricitabine):

Once the drug is swallowed, both the molecules carry out their activities in unique ways. Tenofovir takes around 40 minutes to 1 hour whereas, emtricitabine requires 1-2 hours for absorbing in our system. However, when it comes to excretion, 17 hours are enough for tenofovir to expel out 50% of the drug i.e. 7 hours (10 hours) higher than emtricitabine.

Side-effects of Tenof EM (Tenofovir disoproxil fumarate + Emtricitabine):

Patients with HIV-1 infection Patients who took the drug for reducing the incidence of HIV-1 infection
Difficulty in sleeping (Insomnia) Headache
Rashes on the skin Pain in the abdomen (stomach area)
Tiredness (Fatigue) Loss of weight
Diarrhea
Headache
Nausea

Note: Tenof EM (Tenofovir disoproxil fumarate + Emtricitabine) may show other side-effects too, for additional information please consult your doctor  

Severe conditions associated with administration of Tenof EM (Tenofovir disoproxil fumarate + Emtricitabine):

There are certain conditions wherein either discontinuing the treatment or the component or drug itself could lead to severe complications. Under such scenarios, it is crucial to consult your doctor immediately for safety. These include,

  • Severe acute complications in the liver with Hepatitis B viral infection
  • Acute kidney failure
  • Inflammation occurring due to immune reconstitution syndrome
  • Reduced bone mineral density (Weakened bones)
  • Excessive amount of lactic acid in the blood (lactic acidosis)
  • Hepatotoxicity

Warnings for HIV-1 PrEP patients:

  • Patients should avoid (Tenofovir disoproxil fumarate + Emtricitabine) unless they are confirmed as HIV-negative
  • Use all possible contraceptive methods for preventing the transmission of new HIV-1 infection
  • Make sure that your partner isn’t HIV-1 positive nor taking other anti-HIV medications
  • Undertake regular HIV-1 testing (3 months or when your doctor suggests)
  • Avoid missing any dose of (Tenofovir disoproxil fumarate + Emtricitabine)
Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Tenof EM”

Your email address will not be published. Required fields are marked *